Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202508513258189Phase 3Recruiting
Phase 3, randomised trial of tranexamic acid in Impacted lower third molar (2 arms), sponsored by Taofeek Akinniyi. Primary endpoints: Postoperative pain, Postoperative swelling and 1 more. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202508513258189.